1. Home
  2. STTK vs YYGH Comparison

STTK vs YYGH Comparison

Compare STTK & YYGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STTK
  • YYGH
  • Stock Information
  • Founded
  • STTK 2016
  • YYGH 2010
  • Country
  • STTK United States
  • YYGH Singapore
  • Employees
  • STTK N/A
  • YYGH N/A
  • Industry
  • STTK Biotechnology: Pharmaceutical Preparations
  • YYGH
  • Sector
  • STTK Health Care
  • YYGH
  • Exchange
  • STTK Nasdaq
  • YYGH NYSE
  • Market Cap
  • STTK 37.6M
  • YYGH 40.2M
  • IPO Year
  • STTK 2020
  • YYGH 2024
  • Fundamental
  • Price
  • STTK $0.83
  • YYGH $2.91
  • Analyst Decision
  • STTK Hold
  • YYGH
  • Analyst Count
  • STTK 4
  • YYGH 0
  • Target Price
  • STTK $3.00
  • YYGH N/A
  • AVG Volume (30 Days)
  • STTK 401.8K
  • YYGH 299.5K
  • Earning Date
  • STTK 07-31-2025
  • YYGH 08-21-2025
  • Dividend Yield
  • STTK N/A
  • YYGH N/A
  • EPS Growth
  • STTK N/A
  • YYGH N/A
  • EPS
  • STTK N/A
  • YYGH N/A
  • Revenue
  • STTK $4,606,000.00
  • YYGH $41,103,389.00
  • Revenue This Year
  • STTK N/A
  • YYGH N/A
  • Revenue Next Year
  • STTK N/A
  • YYGH N/A
  • P/E Ratio
  • STTK N/A
  • YYGH N/A
  • Revenue Growth
  • STTK 69.65
  • YYGH 29.37
  • 52 Week Low
  • STTK $0.69
  • YYGH $0.72
  • 52 Week High
  • STTK $4.99
  • YYGH $3.08
  • Technical
  • Relative Strength Index (RSI)
  • STTK 39.19
  • YYGH N/A
  • Support Level
  • STTK $0.77
  • YYGH N/A
  • Resistance Level
  • STTK $0.91
  • YYGH N/A
  • Average True Range (ATR)
  • STTK 0.08
  • YYGH 0.00
  • MACD
  • STTK -0.02
  • YYGH 0.00
  • Stochastic Oscillator
  • STTK 16.23
  • YYGH 0.00

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About YYGH YY GROUP HOLDING LIMITED

YY Group Holding Ltd is a data and technology-driven company focused on developing enterprise intelligent labor matching services and smart cleaning services, founded in Singapore. Through its subsidiaries, it provides enterprise manpower outsourcing and smart cleaning services in Singapore, Malaysia, and other countries. The group's reportable segments are Manpower outsourcing services and Cleaning Service. Maximum revenue is generated from the Cleaning Service segment, which is engaged in acting as a contractor to provide long-term cleaning services to hotels and shopping malls, including the areas of toilets, common areas, bin centers, elevators, etc. Geographically, a majority of the group's revenue is generated from its operations in Singapore and Malaysia.

Share on Social Networks: